S. 3618: No Fentanyl on Social Media Act

This bill, known as the No Fentanyl on Social Media Act, aims to address the issue of minors accessing fentanyl through social media platforms. Here are the main components of the legislation:

Report Requirement

The bill mandates that the Federal Trade Commission (FTC) must submit a report to Congress within one year of its enactment. This report will focus on several key areas:

• How prevalent and accessible fentanyl is for minors on social media platforms.
• The health impacts and safety risks associated with minors accessing fentanyl.
• Methods used by drug sellers to promote and sell fentanyl on social media.
• Social media platform features that may facilitate or hinder minors' access to fentanyl.
• Current practices and policies of social media platforms regarding the sale of fentanyl and their effectiveness.
• Actions taken by law enforcement and the medical community to tackle the issue.
• Recommendations for Congress on effective measures to prevent minors from accessing fentanyl on these platforms.

Consultation with Stakeholders

In preparing the report, the FTC is required to consult with various stakeholders, including:

• Parents
• Representatives from social media platforms
• Law enforcement officials
• Medical professionals
• Other relevant experts

Information Confidentiality

The FTC, in coordination with the Attorney General, has the authority to redact specific information in the report that pertains to law enforcement strategies to protect their effectiveness.

Definitions

Several terms are defined in the bill, including:

• Commission: Refers to the Federal Trade Commission.
• Fentanyl: Includes any fentanyl analogue and fentanyl-related substances.
• Minor: Defined as an individual under the age of 18.
• Social Media Platform: Defined as a public-facing website or app that allows user-generated content, excluding broadband service providers and email services.

Relevant Companies

None found.